Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Antibody and Peptide Therapeutics

Katja Arndt's Biography



Katja Arndt, Professor, University of Potsdam

Katja M. Arndt is Professor of Molecular Biotechnology at the University of Potsdam. She received her Ph.D. in Biochemistry under the supervision of Professor Andreas Plückthun, University of Zurich, Switzerland, and Professor Tom Alber, University of California, Berkeley. With the acceptance to the Emmy-Noether Excellence program of the German Research Foundation (DFG) in 2003, Katja M. Arndt became head of the group 'Protein Engineering in Biosystems' in the Department of Biology, University of Freiburg, Germany. In 2008, she became a principle investigator in the excellence cluster 'BIOSS' (biological signaling studies) and was appointed as Junior Fellow in the School of Life Sciences (LIFENET) of the Freiburg Institute for Advanced Studies (FRIAS). She was appointed to the faculty of the University of Potsdam as a Full Professor of Molecular Biotechnology in 2010. Her academic achievements have been recognized by many awards and scholarships. Her work focuses on evolutionary protein engineering utilizing different selection systems. She pioneered the field of interfering peptides for disrupting protein-protein interactions. Recently she was involved in tailoring a viral system for cytoplasmic gene delivery to tumor cells.

Katja Arndt Image

Targeting Protein-Protein Interactions with Interfering Peptides

Wednesday, 20 July 2011 at 14:45

Add to Calendar ▼2011-07-20 14:45:002011-07-20 15:45:00Europe/LondonTargeting Protein-Protein Interactions with Interfering Peptides SELECTBIOenquiries@selectbiosciences.com

Protein-protein interaction surfaces are attractive yet challenging targets for disease intervention. Combine rational design with in-vivo and in-vitro selection, we generate peptides specifically targeting intracellular protein interaction domains. Inhibitor activity can be controlled via photo-switchable linkers, and D-peptides show enhanced proteolytic stability.


Add to Calendar ▼2011-07-20 00:00:002011-07-21 00:00:00Europe/LondonAntibody and Peptide TherapeuticsSELECTBIOenquiries@selectbiosciences.com